A? Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

A? Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development.

Inyushin MY, Sanabria P, Rojas L, Kucheryavykh Y, Kucheryavykh L. A? Peptide Originated from Platelets Promises New Strategy in Anti-Alzheimer's Drug Development. Biomed Res Int. 2017; 2017:3948360.

View in: PubMed

authors with profiles

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support